小児がん患者の機能改善介入:系統的レビューおよびメタアナリシスプロトコル
Kellyane Munick Holanda1,2, Jamile Vivas Costa3, Wallingson Michael Gonçalves Pereira4
1Facultade de Fisioterapia, Universidade da Coruna, A Coruña, Spain kellyanemunick@gmail.com.
BMJ open
|February 26, 2026
まとめ
この系統的レビューは、小児がん患者を対象とした機能に基づく介入を評価するものです。この集団における機能的アウトカムおよび生活の質の改善に関するエビデンスをまとめることを目的としています。
科学分野:
- 小児腫瘍学;リハビリテーション医学;系統的レビュー方法論
背景:
- がんは、世界中の小児および青年における死亡および罹患の主要な原因です。;機能に基づく介入は、小児がん患者にとって非常に重要です。;これらの介入に関するエビデンスの包括的な要約が必要です。
研究 の 目的:
- 小児がん患者に対する機能に基づく介入の有効性に関するエビデンスを系統的にレビューし、要約すること。;これらの介入が機能指標および健康関連の生活の質に与える影響を評価すること。;研究のギャップを特定し、臨床実践に情報を提供すること。
主な方法:
- PRISMA 2020およびCochrane Handbookガイドラインに従った系統的レビュー。;複数のデータベース(PubMed、Embase、Web of Scienceなど)および臨床試験登録簿を検索。;小児がん患者における機能に基づく介入を評価するランダム化比較試験の包含。;Cochrane Risk of Bias Tool 2を使用したバイアスのリスク評価。;R統計ソフトウェアを使用したナラティブ合成およびメタアナリシス(可能であれば)。;Grading of Recommendations Assessment, Development and Evaluation (GRADE)を使用してエビデンスの確実性を評価。
主要な成果:
- レビュー完了後に結果が利用可能になり次第、このセクションを記入します。
結論:
- レビュー完了後に結論が導き出され次第、このセクションを記入します。
関連する概念動画
Pharmacokinetics in Pediatric Patients: Drug Metabolism
289
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
289
Cancer Survival Analysis
805
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
805
Cancer Therapies
10.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Nursing Interventions II: Selecting and Classifying the Nursing Interventions
3.6K
Creating and executing a nursing diagnosis helps nurses plan care and guide patient, family, and community interventions. They are developed based on a patient's physical evaluation and support measuring the outcomes. It is not recommended to select random interventions throughout the planning process. Instead, consider the following six essential factors when choosing interventions:
3.6K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
384
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
384

